These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19280348)

  • 21. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerodynamic particle size of metered-dose inhalers determined by the quartz crystal microbalance and the Andersen cascade impactor.
    Tzou TZ
    Int J Pharm; 1999 Sep; 186(1):71-9. PubMed ID: 10469925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
    Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
    J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs.
    Stein SW; Sheth P; Younis US; Mogalian E; Myrdal PB
    Mol Pharm; 2015 Sep; 12(9):3455-67. PubMed ID: 26258647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    AAPS PharmSciTech; 2015 Feb; 16(1):192-201. PubMed ID: 25273026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor.
    Doub WH; Adams WP; Wokovich AM; Black JC; Shen M; Buhse LF
    Pharm Res; 2012 Nov; 29(11):3122-30. PubMed ID: 22752252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals.
    Tougas TP; Goodey AP; Hardwell G; Mitchell J; Lyapustina S
    AAPS PharmSciTech; 2017 Feb; 18(2):451-461. PubMed ID: 27068528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 L.
    Mohammed H; Arp J; Chambers F; Copley M; Glaab V; Hammond M; Solomon D; Bradford K; Russell T; Sizer Y; Nichols SC; Roberts DL; Shelton C; Greguletz R; Mitchell JP
    AAPS PharmSciTech; 2014 Oct; 15(5):1126-37. PubMed ID: 24871551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimizing variability of cascade impaction measurements in inhalers and nebulizers.
    Bonam M; Christopher D; Cipolla D; Donovan B; Goodwin D; Holmes S; Lyapustina S; Mitchell J; Nichols S; Pettersson G; Quale C; Rao N; Singh D; Tougas T; Van Oort M; Walther B; Wyka B
    AAPS PharmSciTech; 2008; 9(2):404-13. PubMed ID: 18431675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
    Smith KJ; Chan HK; Brown KF
    J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Disposable and Traditional Accessory Devices for Use With a Pressurized Metered-Dose Inhaler.
    Saeed H; Abdelrahim ME; Rabea H; Salem HF
    Respir Care; 2020 Mar; 65(3):320-325. PubMed ID: 31455686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
    Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
    Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internal Volumes of Pharmaceutical Compendial Induction Port, Next-Generation Impactor With and Without Its Pre-separator, and Several Configurations of the Andersen Cascade Impactor With and Without Pre-separator.
    Roberts DL; Chambers F; Copley M; Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):214-229. PubMed ID: 32101074
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
    Chambers F; Ludzik A
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.